News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
243,748 Results
Type
Article (5802)
Company Profile (20)
Press Release (237926)
Section
Business (87626)
Career Advice (470)
Deals (16469)
Drug Delivery (9)
Drug Development (21229)
Employer Resources (32)
FDA (4044)
Job Trends (4547)
News (129698)
Policy (8408)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (1)
Academia (335)
Adcomms (3)
Allergies (8)
Alliances (16170)
ALS (18)
Alzheimer's disease (305)
Antibody-drug conjugate (ADC) (10)
Approvals (4058)
Artificial intelligence (42)
Autoimmune disease (4)
Automation (2)
Bankruptcy (107)
Best Places to Work (3387)
Biosimilars (11)
Biotechnology (28)
Bladder cancer (9)
Brain cancer (8)
Breast cancer (64)
Cancer (450)
Cardiovascular disease (22)
Career advice (400)
Career pathing (2)
CAR-T (28)
Cell therapy (100)
Cervical cancer (2)
Clinical research (17669)
Collaboration (167)
Compensation (137)
Complete response letters (3)
COVID-19 (449)
CRISPR (7)
C-suite (86)
Cystic fibrosis (16)
Data (500)
Depression (7)
Diabetes (41)
Diagnostics (2243)
Digital health (3)
Diversity, equity & inclusion (13)
Drug discovery (26)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (10)
Earnings (42447)
Editorial (1)
Employer branding (6)
Employer resources (33)
Events (40259)
Executive appointments (285)
FDA (4268)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (199)
Gene editing (15)
Generative AI (2)
Gene therapy (42)
GLP-1 (118)
Government (502)
Guidances (16)
Healthcare (5562)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (11)
Indications (5)
Infectious disease (466)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (13)
Interviews (57)
IPO (8390)
IRA (3)
Job creations (1257)
Job search strategy (365)
Kidney cancer (6)
Labor market (4)
Layoffs (106)
Leadership (4)
Legal (2670)
Liver cancer (17)
Lung cancer (47)
Lymphoma (26)
Management (11)
Manufacturing (51)
MASH (24)
Medical device (4290)
Medtech (4292)
Mergers & acquisitions (8280)
Metabolic disorders (113)
Multiple sclerosis (9)
NASH (6)
Neurodegenerative disease (8)
Neuropsychiatric disorders (2)
Neuroscience (399)
NextGen: Class of 2025 (1791)
Non-profit (789)
Northern California (824)
Now hiring (2)
Obesity (50)
Opinion (31)
Ovarian cancer (14)
Pain (14)
Pancreatic cancer (18)
Parkinson's disease (21)
Partnered (8)
Patents (25)
Patient recruitment (24)
Peanut (4)
People (26301)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (5240)
Phase II (7785)
Phase III (6075)
Pipeline (424)
Policy (4)
Postmarket research (658)
Preclinical (2066)
Press Release (67)
Prostate cancer (27)
Psychedelics (5)
Radiopharmaceuticals (120)
Rare diseases (66)
Real estate (2011)
Recruiting (9)
Regulatory (5598)
Reports (14)
Research institute (349)
Resumes & cover letters (68)
Rett syndrome (2)
Schizophrenia (23)
Series A (26)
Series B (18)
Service/supplier (2)
Sickle cell disease (8)
Southern California (621)
Special edition (1)
Sponsored (4)
Startups (1121)
State (1)
Stomach cancer (1)
Supply chain (10)
United States (6747)
Vaccines (55)
Venture capitalists (3)
Webinars (5)
Weight loss (19)
Women's health (1)
Date
Today (47)
Last 7 days (231)
Last 30 days (1056)
Last 365 days (11609)
2025 (2168)
2024 (12201)
2023 (14503)
2022 (20419)
2021 (21842)
2020 (19700)
2019 (14289)
2018 (10999)
2017 (10865)
2016 (9993)
2015 (13151)
2014 (10359)
2013 (8347)
2012 (9039)
2011 (9442)
2010 (9255)
Location
Africa (198)
Alabama (14)
Alaska (2)
Arizona (62)
Arkansas (1)
Asia (12110)
Australia (1654)
California (1733)
Canada (988)
China (60)
Colorado (79)
Connecticut (94)
Delaware (29)
Europe (25711)
Florida (242)
Georgia (35)
Idaho (23)
Illinois (107)
India (4)
Indiana (70)
Japan (65)
Kansas (25)
Kentucky (11)
Louisiana (5)
Maine (38)
Maryland (207)
Massachusetts (1442)
Michigan (101)
Minnesota (133)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (14)
Nevada (23)
New Hampshire (23)
New Jersey (628)
New Mexico (8)
New York (472)
North Carolina (325)
North Dakota (2)
Northern California (824)
Ohio (51)
Oklahoma (6)
Oregon (3)
Pennsylvania (338)
Puerto Rico (1)
Rhode Island (11)
South America (305)
South Carolina (4)
Southern California (621)
Tennessee (36)
Texas (241)
Utah (58)
Virginia (34)
Washington D.C. (7)
Washington State (155)
West Virginia (2)
Wisconsin (28)
243,748 Results for "tearclear corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sharp Therapeutics Corp. Completes Share Consolidation
January 27, 2025
·
3 min read
Press Releases
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
March 5, 2025
·
20 min read
Press Releases
Sharp Therapeutics Corp. Announces Share Consolidation
January 16, 2025
·
4 min read
Press Releases
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
February 6, 2025
·
8 min read
Press Releases
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
January 22, 2025
·
2 min read
Press Releases
ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol “NAGE” Effective March 19, 2025
March 13, 2025
·
3 min read
Protect Pharmaceutical Corp. Issues Corporate Update
Protect Pharmaceutical Corp.'s (OTC: PRTT) (“Company”) President, Ali Yildiz, provides its shareholders with the following informational update: “July 1, 2024 Dear Shareholders: The Company’s PCAOB audit for the fiscal year of 2023 is near completion.
July 1, 2024
·
4 min read
Press Releases
NaviFUS Corp. Leverages Taiwan’s Advanced Chip Technology to Lead Non-Invasive Precision Medicine for Brain Disorders
February 20, 2025
·
3 min read
Press Releases
Tanke Biosciences Corp Announces Appointment of Vincent Renz as Chief Executive Officer and Member of the Board of Directors
February 13, 2025
·
3 min read
Press Releases
The Joint Corp. to Host Conference Call on Thursday, March 13th to Discuss Fourth Quarter and Year-end 2024 Results
February 20, 2025
·
2 min read
1 of 24,375
Next
